CStone Pharmaceuticals
HKEX:2616

Watchlist Manager
CStone Pharmaceuticals Logo
CStone Pharmaceuticals
HKEX:2616
Watchlist
Price: 5.2 HKD -2.99%
Market Cap: 7.1B HKD

Intrinsic Value

The intrinsic value of one CStone Pharmaceuticals stock under the Base Case scenario is hidden HKD. Compared to the current market price of 5.2 HKD, CStone Pharmaceuticals is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

CStone Pharmaceuticals Intrinsic Value
HIDDEN
Show
Base Case Scenario

Valuation History
CStone Pharmaceuticals

Intrinsic Value History
Dive into the past to invest in the future

CStone Pharmaceuticals looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether CStone Pharmaceuticals usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Compare CStone Pharmaceuticals to

Fundamental Analysis

Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about CStone Pharmaceuticals?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about CStone Pharmaceuticals
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
CStone Pharmaceuticals

Current Assets 1.1B
Cash & Short-Term Investments 672.9m
Receivables 83.9m
Other Current Assets 333m
Non-Current Assets 303.6m
Long-Term Investments 9m
PP&E 130.5m
Intangibles 161.4m
Other Non-Current Assets 2.6m
Efficiency

Free Cash Flow Analysis
CStone Pharmaceuticals

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
CStone Pharmaceuticals

Revenue
407.2m CNY
Cost of Revenue
-167.1m CNY
Gross Profit
240.2m CNY
Operating Expenses
-322.1m CNY
Operating Income
-81.9m CNY
Other Expenses
-9.3m CNY
Net Income
-91.2m CNY
Fundamental Scores

Profitability Score
Profitability Due Diligence

CStone Pharmaceuticals's profitability score is hidden . The higher the profitability score, the more profitable the company is.

hidden
Profitability
Score

CStone Pharmaceuticals's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

CStone Pharmaceuticals's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Negative Net Debt
Low D/E
Short-Term Solvency
Long-Term Solvency
hidden
Solvency
Score

CStone Pharmaceuticals's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
CStone Pharmaceuticals

Wall Street analysts forecast CStone Pharmaceuticals stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CStone Pharmaceuticals is 2.83 HKD with a low forecast of 2.8 HKD and a high forecast of 2.91 HKD.

Lowest
Price Target
2.8 HKD
46% Downside
Average
Price Target
2.83 HKD
46% Downside
Highest
Price Target
2.91 HKD
44% Downside
View Analyst Estimates
View Analyst Estimates

Dividends

CStone Pharmaceuticals
does not pay dividends
Shareholder Yield

Current shareholder yield for CStone Pharmaceuticals is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one CStone Pharmaceuticals stock?

The intrinsic value of one CStone Pharmaceuticals stock under the Base Case scenario is hidden HKD.

Is CStone Pharmaceuticals stock undervalued or overvalued?

Compared to the current market price of 5.2 HKD, CStone Pharmaceuticals is hidden .

Back to Top